Citation: M. Feldman et al., Effects of low-dose aspirin on serum C-reactive protein and thromboxane B-2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay, J AM COL C, 37(8), 2001, pp. 2036-2041
Authors:
Devaraj, S
Hollingworth, DG
Schroeder, RG
Citation: S. Devaraj et al., Generic manufacturing strategies: an empirical test of two configurationaltypologies, J OPER MANA, 19(4), 2001, pp. 427-452
Authors:
O'Byrne, D
Devaraj, S
Islam, KN
Collazo, R
McDonald, L
Grundy, S
Jialal, I
Citation: D. O'Byrne et al., Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy, METABOLISM, 50(2), 2001, pp. 207-215
Citation: E. Conlon et al., The relationship between initial quality perceptions and maintenance behavior: The case of the automotive industry, MANAG SCI, 47(9), 2001, pp. 1191-1202
Citation: S. Devaraj et al., Divergence between LDL oxidative susceptibility and urinary F-2-isoprostanes as measures of oxidative stress in type 2 diabetes, CLIN CHEM, 47(11), 2001, pp. 1974-1979
Authors:
Jialal, I
Stein, D
Balis, D
Grundy, SM
Adams-Huet, B
Devaraj, S
Citation: I. Jialal et al., Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy onhigh sensitive C-reactive protein levels, CIRCULATION, 103(15), 2001, pp. 1933-1935
Authors:
Meira, LB
Devaraj, S
Kisby, GE
Burns, DK
Daniel, RL
Hammer, RE
Grundy, S
Jialal, I
Friedberg, EC
Citation: Lb. Meira et al., Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress, CANCER RES, 61(14), 2001, pp. 5552-5557
Citation: N. Kaul et al., Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects, AM J CARD, 87(11), 2001, pp. 1320-1323
Authors:
O'Byrne, D
Grundy, S
Packer, L
Devaraj, S
Baldenius, K
Hoppe, PP
Kraemer, K
Jialal, I
Traber, MG
Citation: D. O'Byrne et al., Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans, FREE RAD B, 29(9), 2000, pp. 834-845
Citation: S. Devaraj et I. Jialal, Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and Type 2 diabetic patients, FREE RAD B, 29(8), 2000, pp. 790-792
Citation: I. Jialal et S. Devaraj, Vitamin E supplementation and cardiovascular events in high-risk patients., N ENG J MED, 342(25), 2000, pp. 1917-1917
Authors:
Islam, KN
O'Byrne, D
Devaraj, S
Palmer, B
Grundy, SM
Jialal, I
Citation: Kn. Islam et al., Alpha-tocopherol supplementation decreases the oxidative susceptibility ofLDL in renal failure patients on dialysis therapy, ATHEROSCLER, 150(1), 2000, pp. 217-224
Authors:
Hirany, S
O'Byrne, D
Devaraj, S
Jialal, I
Citation: S. Hirany et al., Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease, CLIN CHEM, 46(5), 2000, pp. 667-672
Citation: S. Devaraj et I. Jialal, Low-density lipoprotein postsecretory modification, monocyte function, andcirculating adhesion molecules in type 2 diabetic patients with and without macrovascular complications - The effect of alpha-tocopherol supplementation, CIRCULATION, 102(2), 2000, pp. 191-196
Citation: S. Devaraj et al., Ratio of remnant-like particle cholesterol to serum total triglycerides isa reliable screening test for type III dyslipidaemia, ANN CLIN BI, 37, 2000, pp. 790-791
Citation: S. Devaraj et I. Jialal, alpha-tocopherol decreases interleukin-1 beta release from activated humanmonocytes by inhibition of 5-lipoxygenase, ART THROM V, 19(4), 1999, pp. 1125-1133